Second medical use patents after Warner-Lambert v Generics

Published on
1 min read

After the Supreme Court’s ruling in Warner-Lambert v Generics , clinicians and pharmacists can breathe a sigh of relief that they will not be personally exposed to patent litigation.

After the Supreme Court’s ruling in Warner-Lambert v Generics, clinicians and pharmacists can breathe a sigh of relief that they will not be personally exposed to patent litigation. But the decision raises some questions for innovative pharmaceutical companies. How does it impact the incentives available for researching new uses for existing medicines? our patent experts Alasdair Poore and Mark Pearce discuss the issues.

Click on the link above to download our full briefing.

Mills & Reeve Sites navigation
A tabbed collection of Mills & Reeve sites.
Sites
My Mills & Reeve navigation
Subscribe to, or manage your My Mills & Reeve account.
My M&R

Visitors

Register for My M&R to stay up-to-date with legal news and events, create brochures and bookmark pages.

Existing clients

Log in to your client extranet for free matter information, know-how and documents.

Staff

Mills & Reeve system for employees.